Clinical comparative study of oral contraceptives containing 30 μg ethinylestradiol/150 μg levonorgestrel, and 35 μg ethinylestradiol/250 μg norgestimate in Thai women

Contraception

Volumn 66, Issue 6, 2002, Pages 401-405

  Tantbirojn, Patou ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cycle control; Ethinylestradiol; Levonorgestrel; Norgestimate; Oral contraceptives

Indexed keywords

ETHINYLESTRADIOL; LEVONORGESTREL; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG EFFICACY; EXPERIENCE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL IRREGULARITY; NAUSEA; PREGNANCY; STATISTICAL SIGNIFICANCE; THAILAND; TIME PERCEPTION; VERTIGO; WITHDRAWAL BLEEDING;

ADOLESCENT; ADULT; BLOOD PRESSURE; BODY WEIGHT; CONTRACEPTIVES, ORAL; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; MENSTRUAL CYCLE; NORGESTREL; THAILAND; UTERINE HEMORRHAGE;

EID: 0242286064     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(02)00393-1     Document Type: Article

References (9)

1. Runnebaum B., Grunwald K., Rabe T. The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol) results of an open, multicenter study of 59,701 women . Am J Obstet Gynecol. 166:1992;1963-1968.
2. Corson S.L. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate. Am J Obstet Gynecol. 170:1994;1556-1561.
3. Bringer J. Norgestimate a clinical overview of a new progestin . Am J Obstet Gynecol. 166:1992;1969-1977.
4. Lippman J.S., Shangold G.A. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol. Int J Fertil Women Med. 42:1997;230-239.
5. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use methods. 1996;World Health Organization, Geneva.
6. Loudon N.B., Kirkman R.J.E., Dewsbury J.A. A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30. Eur J Obstet Gynecol Reprod Biol. 34:1990;257-266.
7. Kafrissen M.E. A norgestimate-containing oral contraceptive review of clinical studies . Am J Obstet Gynecol. 167:1992;1196-1202.
8. Serfaty D., Vree M.L. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinyl estradiol, and either 150 μg desogestrel or 75 μg gestodene. Eur Contracept Reprod Health Care. 3:1998;179-189.
9. Bounds W., Vessey M., Wiggins P. A randomized double-blind trial of two low dose combined oral contraceptives. Br J Obstet Gynecol. 86:1979;325-329.